Key result
Optimizing PE risk stratification with clinical, imaging, and biomarker data guides appropriate treatment strategies.
Why the study?
Pulmonary embolism remains a leading cause of cardiovascular mortality with heterogeneous outcomes, making optimized risk stratification crucial to improve patient management and clinical outcomes.
Population
Patients with pulmonary embolism
Design
Review
Authors
Loading...
May aid therapy selection in normotensive PE; leaves open prospective validation of integrated risk models.
Optimizing risk stratification of patients with normotensive pulmonary embolism is essential to guide appropriate treatment strategies, including the use of thrombolysis and new anticoagulants.
Penaloza et al. (2012) conducted a review in Pulmonary embolism. Risk stratification and treatment strategies was evaluated. Optimizing risk stratification of patients with pulmonary embolism using clinical features, imaging, and biomarkers is essential to guide appropriate treatment strategies.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: